Showing results (101-110 of 197) with videos related to
Sort By:
Pageof 20
Intensive Care Medicine|January 1, 1985
Moxalactam in nosocomial infections with Serratia marcescensT Mall, F Follath, M Salfinger, et al.European Journal of Clinical Pharmacology|January 1, 1990
Predictability and intraindividual variability of serum theophylline concentrations in patients with obstructive lung disease: 12-h versus 24-h dosingO Schmidlin, S Vozeh, B Keller, et al.Clinical Pharmacokinetics|July 1, 1984
Rapid prediction of individual dosage requirements for lignocaineS Vozeh, M Berger, M Wenk, et al.La Clinica Terapeutica|August 15, 1989
[Monitoring of plasma concentrations of aminoglycosides]P De Gregoris, F Follath, F Traditi, et al.Deutsche Medizinische Wochenschrift (1946)|October 31, 1975
[Cardiac myxoma (author's transl)]K E Frede, F Follath, J Hasse, et al.Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|May 18, 1993
[Possibilities of catheter therapy in vascular stenosis, vascular abnormalities, tumors and hemorrhages. Synopsis of an interdisciplinary colloquium]F W Amann, E Schneider, A Valavanis, et al.Journal of Hepatology|November 3, 2001
Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondriaM Spaniol, R Bracher, H R Ha, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2001
Metabolism of amiodarone (Part III): identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono-N-desethylamiodaroneP Kozlik, H R Ha, B Stieger, et al.Journal of Cardiovascular Pharmacology|May 1, 1990
Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivoW E Haefeli, M J Bargetzi, F Follath, et al.Medical and Pediatric Oncology|January 1, 1997
Langerhans'-cell histiocytosis in adultsI Baumgartner, A von Hochstetter, B Baumert, et al.Pageof 20